MAP2K7 and melanoma: In addition, our CCK8 (Fig. 4e) and colony formation assays (Fig. 4f) showed that blocking either the expression of POU4F1 by shRNA or the activation of MEK/ERK pathway by PD98059 restored the sensitivity of melanoma cells to Vemurafenib.